GlassScriptPhysician profile
Akshaya Jain
NPI 1770018624
$410.32
in general payments reported to CMS, 2019-2025
12 companies · $2.85 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.28 · 2022: $88.53 · 2023: $264 · 2024: $37.63 · 2025: $2.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $304.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $64.81 | 2022-2025 | Nexplanon, Jada System |
| Pfizer INC. | $57.13 | 2023-2024 | |
| Exeltis, USA INC. | $53.94 | 2021-2023 | Slynd |
| Mayne Pharma Commercial LLC | $39.14 | 2023 | |
| Myriad Women'S Health, INC. | $37.72 | 2023 | Myrisk |
| Astellas Pharma US INC | $34.85 | 2023 | Veozah |
| Millicent US INC | $25.71 | 2023 | Intrarosa |
| Hologic Sales and Service, LLC | $23.92 | 2022 | |
| Sumitomo Pharma America, INC. | $21.77 | 2023 | Myfembree |
| Abbvie INC. | $20.53 | 2023 | |
| Evofem Biosciences, INC. | $16.73 | 2022 | |
| Therapeuticsmd, INC. | $14.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akshaya Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.